Comment from National Eczema Association

Summary: The National Eczema Association (NEA) supports the FDA's request for information on Patient-Focused Drug Development (PFDD) meetings, highlighting how past meetings have informed their research and advocacy. They recommend establishing a transparent follow-up process for Voice of the Patient Reports and creating a publicly available compendium of collective learnings from all PFDD meetings.